| Steven Robert Meno, | |
|
1501 W Chisholm St, Alpena, MI 49707-1401 | |
| (989) 464-9069 | |
| Not Available |
| Full Name | Steven Robert Meno |
|---|---|
| Gender | Male |
| Speciality | Psychologist |
| Location | 1501 W Chisholm St, Alpena, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386047835 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 6301005543 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Steven Robert Meno, 1501 W Chisholm St, Alpena, MI 49707-1401 Ph: (989) 464-9069 | Steven Robert Meno, 1501 W Chisholm St, Alpena, MI 49707-1401 Ph: (989) 464-9069 |
News Archive
Halozyme Therapeutics, Inc. today announced that the first healthy subject has been dosed in a Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of a subcutaneous formulation of rivipansel, a compound discovered by GlycoMimetics, Inc. and being developed by Pfizer Inc., using Halozyme's ENHANZE formulation.
According to a new study, the drug donepezil measurably slows the rate of brain shrinkage in some patients with mild cognitive impairment, a pre-Alzheimer's disease condition. The shrinkage was measured by magnetic resonance imaging (MRI).
Cancer Research Institute, a U.S. nonprofit organization founded in 1953 to advance the science of tumor immunology and foster the discovery and development of new cancer immunotherapies, announced today that its Cancer Vaccine Acceleration Fund, a joint initiative with the Ludwig Institute for Cancer Research, has completed a new investment agreement with Oncovir, a biotechnology company based in Washington, D.C., to enable the production of the immunological stimulant Hiltonol- (Poly-ICLC).
Seattle Genetics, Inc. today announced that Genentech, Inc., a wholly owned member of the Roche Group, will pay $9.5 million to renew exclusive licenses to specific targets and extend the research term under the parties' existing antibody-drug conjugate (ADC) collaboration agreement. Under the terms of the agreement, Genentech has rights to use Seattle Genetics' ADC technology with antibodies against targets selected by Genentech.
WHO has delivered medicines to tackle an outbreak of diphtheria in Yemen, warning that sustained humanitarian access is critical to stopping its spread.
› Verified 9 days ago
Katherine Witkowski, TLLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 112 W Chisholm St, Alpena, MI 49707 Phone: 989-340-1645 | |
Laura M Marcotte, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 400 Johnson St, Alpena, MI 49707 Phone: 989-358-7633 | |
Donald Laird, LLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 400 Johnson St, Alpena, MI 49707 Phone: 989-356-2161 Fax: 989-354-5898 | |
Tiffany Ann Greenwald, CMA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 400 Johnson St, Alpena, MI 49707 Phone: 989-356-2161 Fax: 989-354-5898 | |
Mr. Frank Jacques Van Goethem, MA, LLP, LMSW Psychologist Medicare: Medicare Enrolled Practice Location: 400 Johnson St, Alpena, MI 49707 Phone: 989-356-2161 | |
Daniel C Schackmann, MA LLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1501 W Chisholm St, Alpena, MI 49707 Phone: 989-356-7242 Fax: 989-356-7320 |